Stocksigma LogoStocksigma Logo

Thyrocare Technologies Schedules Board Meeting for Q2 FY27 Financial Results

Thyrocare Technologies Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the unaudited standalone and

Thyrocare Technologies Schedules Board Meeting for Q2 FY27 Financial Results

Thyrocare Technologies Ltd 路 Intimation 路 29 Oct 2026, 5:30 am

Thyrocare Technologies Schedules Board Meeting for Q2 FY27 Financial Results Thyrocare Technologies Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The company noted that the insider trading window, closed since 1st Oct'26 for designated persons and their immediate relatives, will reopen 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Thyrocare Technologies Ltd

All Thyrocare Technologies Ltd announcements